Results

Total Results: 1,528 records

Showing results for "drugs".

1. Hypertension-Drugs-Utilization Research (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/hypertension-drugs-utilization_research.pdf
   January 25, 2011 - Further, it examines costs of antihypertensive drugs. … In 2009, the total drug cost for antihypertensive drugs was $4.3 bil- lion. … Identification of Antihypertensive Drugs and Classes: Oral prescriptions of anti- hypertensive drugs … Table 2: Antihypertensive drugs examined in this brief Drug Class Drugs Angiotensin-converting enzyme … Use of antihypertensive drugs by Medicare enrollees: does type of drug coverage matter?

2. Diabetes-Drugs-Utilization Research (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-drugs-utilization_research.pdf
   March 01, 2011 - Utilization of antidiabetic drugs among Medicare beneficiaries with diabetes, 2006-2009 Diabetes Treatment … Several types of insulin and other injectable drugs such as amylin analogs and glucagon-like peptide … Drugs Aging 2009;26(Suppl 1):53-62. 3. Abbatecola AM, Maggi S, Paolisso G. … Drugs Aging 2008;25(11):913-25. 4. Feil D, Weinreb J, Sultzer D. … Utilization of antidiabetic drugs among Medicare beneficiaries with diabetes, 2006-2009.

3. Cancer-Drugs-Utilization Research (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization_research.pdf
   January 01, 2011 - Drug Information, DrugPoints, Clinical Pharmacology, DRUGDEX, National Comprehensive Cancer Network Drugs

4. Club Drugs | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/health-topics/club-drugs

5. Cancer-Drugs-Utilization-Cost Research (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization-cost_research.pdf
   January 01, 2011 - expen- ditures treated either cancer or potential sequelae of cancer (e.g., anemia).4 Two of these drugs … Using 2006 data, the Centers for Medicare & Medicaid Services (CMS) reported on the top 100 Part D drugs … Limits on Medicare’s ability to control rising spending on cancer drugs. … Top 100 drugs by utilization and class variations in generic dispensing rates. … Available at: www.aarp.org/health/drugs- supplements/info-2007/fs136_biologics.html.

6. Drugs and Young People | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/health-topics/drugs-and-young-people

7. S13 (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/s13.pdf
   October 01, 2007 - Historically, those who investigate the effects of mar- keted pharmaceuticals have focused on the risk … Unique Problems in the Study of Pharmaceuticals Exposure misclassification is a unique challenge in … Indeed, the confounders of concern are usually other drugs or other diseases. … In addition, studies of pharmaceuticals, especially stud- ies of the effectiveness of pharmaceuticals … CONCLUSIONS The goal of our research community is to optimize the use of pharmaceuticals by improving

8. Data Points #9: Utilization of antidiabetic drugs among Medicare beneficiaries with diabetes, 2006-2009 | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/products/diabetes-drugs-utilization/research

9. Making Healthcare Safer IV: Protocols for High-Risk Drugs: Reducing Adverse Drug Events Related to Anticoagulants | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/products/high-risk-drugs/protocol

10. Data Points #8: Utilization of antihypertensive drug classes among Medicare beneficiaries with hypertension, 2007 to 2009 | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/hypertension-drugs-utilization/research

11. Communicating Harms and Benefits of Prescription Drugs to Healthcare Consumers (ppt file)
    effectivehealthcare.ahrq.gov/sites/default/files/communicating_risk_hickam.ppt
    December 01, 2006 - Communicating Harms and Benefits of Prescription Drugs to Healthcare Consumers Communicating Harms … and Benefits of Prescription Drugs to Healthcare Consumers John M. … Science Center Agency for Healthcare Research and Quality Effective Health Care Program Themes Drugs

12. #14 SUBSTANCE ABUSE (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/substanceabuse_hi_impact.pdf
    January 01, 2012 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Prescription drugs: abuse and addiction. [internet]. … Titan Pharmaceuticals provides probuphine update after meeting with U.S.

13. Data Points #7: Utilization of anticancer biologic products among Medicare beneficiaries, by diagnostic cancer subchapter, 2006-2009 | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/cancer-drugs-utilization/research

14. Chicago-Area DEcIDE Center (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/off-label-use-research-priorities_research.pdf
    May 01, 2009 - years (based from 12/31/06) were coded as 1.0, drugs approved between 4-13 years as 0.5, and drugs … Bayesian approaches to the value of information: implications for the regulation of new pharmaceuticals … c The Drug Safety index value is coded as 1 for drugs with a black box warning, 0.5 for drugs that had … drugs that entered 4 to 13 years ago, and zero for drugs that entered more than 13 years ago and zero … the drugs shifted from the top tier).

15. Migraine-Adults-Executive-130408 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-adults-executive-130408.pdf
    April 01, 2013 - or approved versus off-label drugs. … Discussion All approved drugs, some off-label beta blockers, and the angiotensin inhibiting drugs were … The relative effect size of drugs was moderate: drugs would result in to 200 to 400 cases of clinical … or approved versus off-label drugs. … Modeling choice behavior for new pharmaceutical products.

16. White Paper: Enhancing Systematic Review Methods by Incorporating Unpublished Drug Trials (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/unpublished-drug-trials-white-paper.pdf
    December 01, 2024 - Visit the Drugs@FDA website and navigate to the approval history. c. … Check Drugs@FDA. … Drug maturity Not-so-new drugs Relatively new drugs Older drugs are more likely to have missing and … We focused on three psychiatric drugs. … Regulatory agencies hold the key to improving Cochrane reviews of drugs.

17. Obesity (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/obesity_hi_impact.pdf
    April 17, 2012 - Antiobesity Drugs for Treatment of Obesity  Key Facts: Three drugs are in phase III development for … In December 2010, Arena Pharmaceuticals announced a plan to resubmit the lorcaserin NDA by the end … Arena Pharmaceuticals. Lorcaserin hydrochloride. Drugs Future 2007;32(9):766-70. 12. … Meta-analyses of phase 3 trials show obese and overweight patients taking Arena Pharmaceuticals' … Istanbul: Arena Pharmaceuticals, Inc.; 2011 May 26 [accessed 2011 Nov 16]. [3 p].

18. Reducing Adverse Drug Events Related to Anticoagulant Use in Adults | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/high-risk-drugs/rapid-research

19. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0128_07-01-2009.pdf
    January 01, 2009 - Results of Topic Selection Process & Next Steps  Generic versus brand name antiepileptic drugs … come out against the substitution of „A‟ rated generics, and neurologists use a large amount of brand drugs … In addition, many states include these drugs in their narrow therapeutic index laws. … : All patients with seizures stratified by seizure type Intervention(s): Brand name antiepileptic drugs … Comparator(s): Generic antiepileptic drugs Outcome(s): Seizure control, emergency department visits

20. Data Points #6: Utilization and cost of anticancer biologic products among Medicare beneficiaries, 2006-2009 | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/cancer-drugs-utilization-cost/research